Prenatal immune challenge in rats: Effects of polyinosinic-polycytidylic acid on spatial learning, prepulse inhibition, conditioned fear, and responses to MK-801 and amphetamine

Neurotoxicology and Teratology

Volumn 47, Issue , 2015, Pages 54-65

  Vorhees, Charles V ^a,b   Graham, Devon L ^c   Braun, Amanda A ^a,b   Schaefer, Tori L ^a,b   Skelton, Matthew R ^a,b   Richtand, Neil M ^d   Williams, Michael T ^a,b  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

(+) Amphetamine induced locomotor activity; MK 801 induced locomotor activity; Morris water maze; Polyinosinic polycytidylic acid; Prenatal immune activation; Rat

Indexed keywords

AMPHETAMINE; DIZOCILPINE; POLYINOSINIC POLYCYTIDYLIC ACID; SODIUM CHLORIDE; DIZOCILPINE MALEATE; INTERFERON INDUCING AGENT; NEUROPROTECTIVE AGENT;

ACOUSTIC REFLEX; ANIMAL EXPERIMENT; ANXIETY; ARTICLE; CONDITIONING; DAM (ANIMAL); DARKNESS; EGO; ELEVATED ZERO MAZE TEST; FEAR; FEMALE; FREEZING; IMMUNE RESPONSE; LIGHT; MALE; MARBLE BURYING TEST; MORRIS WATER MAZE TEST; NONHUMAN; OPEN FIELD TEST; PREPULSE INHIBITION; PROGENY; RAT; SEX DIFFERENCE; SPATIAL LEARNING; SPRAGUE DAWLEY RAT; STARTLE REFLEX; WEIGHT GAIN; WEIGHT REDUCTION; WORKING MEMORY; AGE; ANIMAL; AUDITORY STIMULATION; BODY WEIGHT; CHEMICALLY INDUCED; DRUG EFFECTS; EXPLORATORY BEHAVIOR; IMMUNOLOGY; LITTER SIZE; MAZE TEST; NEWBORN; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; SEX RATIO; VISUAL ADAPTATION;

RATTUS;

ACOUSTIC STIMULATION; ADAPTATION, OCULAR; AGE FACTORS; AMPHETAMINE; ANIMALS; ANIMALS, NEWBORN; BODY WEIGHT; CONDITIONING (PSYCHOLOGY); DIZOCILPINE MALEATE; EXPLORATORY BEHAVIOR; FEAR; FEMALE; INTERFERON INDUCERS; LITTER SIZE; MALE; MAZE LEARNING; NEUROPROTECTIVE AGENTS; POLY I-C; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PREPULSE INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; SEX RATIO; SPATIAL LEARNING;

EID: 84912101586     PISSN: 08920362     EISSN: 18729738     Source Type: Journal    
DOI: 10.1016/j.ntt.2014.10.007     Document Type: Article

References (80)

1. Ashdown H., Dumont Y., Ng M., Poole S., Boksa P., Luheshi G.N. The role of cytokines in mediating effects of prenatal infection on the fetus: implications for schizophrenia. Mol Psychiatry 2006, 11:47-55.
2. Atladottir H.O., Thorsen P., Ostergaard L., Schendel D.E., Lemcke S., Abdallah M., et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders. J Autism Dev Disord 2010, 40:1423-1430.
3. Bitanihirwe B.K., Peleg-Raibstein D., Mouttet F., Feldon J., Meyer U. Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia. Neuropsychopharmacology 2010, 35:2462-2478.
4. Bitanihirwe B.K., Weber L., Feldon J., Meyer U. Cognitive impairment following prenatal immune challenge in mice correlates with prefrontal cortical AKT1 deficiency. Int J Neuropsychopharmacol 2010, 13:981-996.
5. Boksa P. Effects of prenatal infection on brain development and behavior: a review of findings from animal models. Brain Behav Immun 2010, 24:881-897.
6. Braun A.A., Skelton M.R., Vorhees C.V., Williams M.T. Comparison of the elevated plus and elevated zero mazes in treated and untreated male Sprague-Dawley rats: effects of anxiolytic and anxiogenic agents. Pharmacol Biochem Behav 2011, 97:406-415.
7. Braun A.A., Graham D.L., Schaefer T.L., Vorhees C.V., Williams M.T. Dorsal striatal dopamine depletion impairs both allocentric and egocentric navigation in rats. Neurobiol Learn Mem 2012, 97(4):402-408.
8. Bronson S.L., Richtand N.M. Developmental consequences of prenatal maternal immune activation. Handbook of schizophrenia spectrum disorders 2011, vol. I:1-25. Springer Science-Business Media B.V, New York.
9. Bronson S.L., Ahlbrand R., Horn P.S., Kern J.R., Richtand N.M. Individual differences in maternal response to immune challenge predict offspring behavior: contribution of environmental factors. Behav Brain Res 2011, 220:55-64.
10. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32:200-202.
11. Brown A.S., Derkits E.J. Prenatal infection and schizophrenia: a review of epidemiologic and translational studies. Am J Psychiatry 2010, 167:261-280.
12. Brown A.S., Susser E.S. In utero infection and adult schizophrenia. Ment Retard Dev Disabil Res Rev 2002, 8:51-57.
13. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry 2004, 61:774-780.
14. Ciaranello A.L., Ciaranello R.D. The neurobiology of infantile autism. Annu Rev Neurosci 1995, 18:101-128.
15. Clarke M.C., Tanskanen A., Huttunen M., Whittaker J.C., Cannon M. Evidence for an interaction between familial liability and prenatal exposure to infection in the causation of schizophrenia. Am J Psychiatry 2009, 166:1025-1030.
16. Cunningham C., Campion S., Teeling J., Felton L., Perry V.H. The sickness behaviour and CNS inflammatory mediator profile induced by systemic challenge of mice with synthetic double-stranded RNA (poly I:C). Brain Behav Immun 2007, 21:490-502.
17. Deverman B.E., Patterson P.H. Cytokines and CNS development. Neuron 2009, 64:61-78.
18. Dickerson D.D., Wolff A.R., Bilkey D.K. Abnormal long-range neural synchrony in a maternal immune activation animal model of schizophrenia. J Neurosci 2010, 30:12424-12431.
19. Fatemi S.H., Emamian E.S., Kist D., Sidwell R.W., Nakajima K., Akhter P., et al. Defective corticogenesis and reduction in Reelin immunoreactivity in cortex and hippocampus of prenatally infected neonatal mice. Mol Psychiatry 1999, 4:145-154.
20. Fatemi S.H., Earle J., Kanodia R., Kist D., Emamian E.S., Patterson P.H., et al. Prenatal viral infection leads to pyramidal cell atrophy and macrocephaly in adulthood: implications for genesis of autism and schizophrenia. Cell Mol Neurobiol 2002, 22:25-33.
21. Fatemi S.H., Pearce D.A., Brooks A.I., Sidwell R.W. Prenatal viral infection in mouse causes differential expression of genes in brains of mouse progeny: a potential animal model for schizophrenia and autism. Synapse 2005, 57:91-99.
22. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2004, 287:R759-R766.
23. Fortier M.E., Luheshi G.N., Boksa P. Effects of prenatal infection on prepulse inhibition in the rat depend on the nature of the infectious agent and the stage of pregnancy. Behav Brain Res 2007, 181:270-277.
24. Geyer M.A. The family of sensorimotor gating disorders: comorbidities or diagnostic overlaps?. Neurotox Res 2006, 10:211-220.
25. Geyer M.A., Swerdlow N.R., Mansbach R.S., Braff D.L. Startle response models of sensorimotor gating and habituation deficits in schizophrenia. Brain Res Bull 1990, 25:485-498.
26. Geyer M.A., Wilkinson L.S., Humby T., Robbins T.W. Isolation rearing of rats produces a deficit in prepulse inhibition of acoustic startle similar to that in schizophrenia. Biol. Psychiatry 1993, 34:361-372.
27. Geyer M.A., Krebs-Thomson K., Braff D.L., Swerdlow N.R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology (Berl) 2001, 156:117-154.
28. Gilmore J.H., Jarskog L.F., Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fetal unit of the rat. J Neuroimmunol 2005, 159:106-112.
29. Giovanoli S., Meyer U. Response to comment on "Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice". Science 2013, 340:811.
30. Giovanoli S., Engler H., Engler A., Richetto J., Voget M., Willi R., et al. Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice. Science 2013, 339:1095-1099.
31. Holson R.R., Pearce B. Principles and pitfalls in the analysis of prenatal treatment effects in multiparous species. Neurotoxicol Teratol 1992, 14:221-228.
32. Howland J.G., Cazakoff B.N., Zhang Altered object-in-place recognition memory, prepulse inhibition, and locomotor activity in the offspring of rats exposed to a viral mimetic during pregnancy. Neuroscience 2012, 201:184-198.
33. Hsiao E.Y., Patterson P.H. Activation of the maternal immune system induces endocrine changes in the placenta via IL-6. Brain Behav Immun 2011, 25:604-615.
34. Hsiao E.Y., McBride S.W., Chow J., Mazmanian S.K., Patterson P.H. Modeling an autism risk factor in mice leads to permanent immune dysregulation. Proc Natl Acad Sci U S A 2012, 109:12776-12781.
35. Ito H.T., Smith S.E., Hsiao E., Patterson P.H. Maternal immune activation alters nonspatial information processing in the hippocampus of the adult offspring. Brain Behav Immun 2010, 24:930-941.
36. Klein J., Hadar R., Gotz T., Manner A., Eberhardt C., Baldassarri J., et al. Mapping brain regions in which deep brain stimulation affects schizophrenia-like behavior in two rat models of schizophrenia. Brain Stimul 2013, 6:490-499.
37. Lazic S.E. Comment on "Stress in puberty unmasks latent neuropathological consequences of prenatal immune activation in mice". Science 2013, 340:811.
38. Lazic S.E., Essioux L. Improving basic and translational science by accounting for litter-to-litter variation in animal models. BMC Neurosci 2013, 14:37.
39. Mattei D., Djodari-Irani A., Hadar R., Pelz A., de Cossio L.F., Goetz T., et al. Minocycline rescues decrease in neurogenesis, increase in microglia cytokines and deficits in sensorimotor gating in an animal model of schizophrenia. Brain Behav Immun 2014, 38:175-184.
40. Mednick S.A., Machon R.A., Huttunen M.O., Bonett D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988, 45:189-192.
41. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci Biobehav Rev 2005, 29:913-947.
42. Meyer U., Feldon J., Schedlowski M., Yee B.K. Immunological stress at the maternal-foetal interface: a link between neurodevelopment and adult psychopathology. Brain Behav Immun 2006, 20:378-388.
43. Meyer U., Nyffeler M., Engler A., Urwyler A., Schedlowski M., Knuesel I., et al. The time of prenatal immune challenge determines the specificity of inflammation-mediated brain and behavioral pathology. J Neurosci 2006, 26:4752-4762.
44. Meyer U., Schwendener S., Feldon J., Yee B.K. Prenatal and postnatal maternal contributions in the infection model of schizophrenia. Exp Brain Res 2006, 173:243-257.
45. Meyer U., Yee B.K., Feldon J. The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?. Neuroscientist 2007, 13:241-256.
46. Meyer U., Feldon J., Fatemi S.H. In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders. Neurosci Biobehav Rev 2009, 33:1061-1079.
47. Meyer U., Feldon J., Yee B.K. A review of the fetal brain cytokine imbalance hypothesis of schizophrenia. Schizophr Bull 2009, 35:959-972.
48. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
49. Moreno J.L., Kurita M., Holloway T., Lopez J., Cadagan R., Martinez-Sobrido L., et al. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HTA and mGlu receptors in the adult offspring. J Neurosci 2011, 31:1863-1872.
50. Nyffeler M., Meyer U., Yee B.K., Feldon J., Knuesel I. Maternal immune activation during pregnancy increases limbic GABAA receptor immunoreactivity in the adult offspring: implications for schizophrenia. Neuroscience 2006, 143:51-62.
51. Oh-Nishi A., Obayashi S., Sugihara I., Minamimoto T., Suhara T. Maternal immune activation by polyriboinosinic-polyribocytidilic acid injection produces synaptic dysfunction but not neuronal loss in the hippocampus of juvenile rat offspring. Brain Res 2010, 1363:170-179.
52. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol Psychiatry 2006, 59:546-554.
53. Patterson P.H. Maternal infection: window on neuroimmune interactions in fetal brain development and mental illness. Curr Opin Neurobiol 2002, 12:115-118.
54. Patterson P.H. Immune involvement in schizophrenia and autism: etiology, pathology and animal models. Behav Brain Res 2009, 204:313-321.
55. Penner J.D., Brown A.S. Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Rev Neurother 2007, 7:797-805.
56. Piontkewitz Y., Arad M., Weiner I. Abnormal trajectories of neurodevelopment and behavior following in utero insult in the rat. Biol Psychiatry 2011, 70:842-851.
57. Richtand N.M., Ahlbrand R., Horn P., Stanford K., Bronson S.L., McNamara R.K. Effects of risperidone and paliperidone pre-treatment on locomotor response following prenatal immune activation. J Psychiatr Res 2011, 220:55-64.
58. Samuelsson A.M., Jennische E., Hansson H.A., Holmang A. Prenatal exposure to interleukin-6 results in inflammatory neurodegeneration in hippocampus with NMDA/GABA(A) dysregulation and impaired spatial learning. Am J Physiol Regul Integr Comp Physiol 2006, 290:R1345-R1356.
59. Sangha S., Greba Q., Robinson P.D., Ballendine S.A., Howland J.G. Heightened fear in response to a safety cue and extinguished fear cue in a rat model of maternal immune activation. Front Behav Neurosci 2014, 8:168.
60. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J Neurosci 2003, 23:297-302.
61. Shi L., Smith S.E., Malkova N., Tse D., Su Y., Patterson P.H. Activation of the maternal immune system alters cerebellar development in the offspring. Brain Behav Immun 2009, 23:116-123.
62. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J Neurosci 2007, 27:10695-10702.
63. Swerdlow N.R., Geyer M.A. Cozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 1993, 44:741-744.
64. Swerdlow N.R., Light G.A., Cadenhead K.S., Sprock J., Hsieh M.H., Braff D.L. Startle gating deficits in a large cohort of patients with schizophrenia: relationship to medications, symptoms, neurocognition, and level of function. Arch Gen Psychiatry 2006, 63:1325-1335.
65. Vorhees C.V. Maze learning in rats: a comparison of performance in two water mazes in progeny prenatally exposed to different doses of phenytoin. Neurotoxicol Teratol 1987, 9:235-241.
66. Vorhees C.V., Williams M.T. Morris water maze: procedures for assessing spatial and related forms of learning and memory. Nat. Protoc 2006, 1:848-858.
67. Vorhees C.V., Williams M.T. Assessing spatial learning and memory in rodents. ILAR J 2014, 55:310-332.
68. Vorhees C.V., Weisenburger W.P., Acuff-Smith K.D., Minck D.R. An analysis of factors influencing complex water maze learning in rats: effects of task complexity, path order and escape assistance on performance following prenatal exposure to phenytoin. Neurotoxicol Teratol 1991, 13:213-222.
69. Vorhees C.V., Herring N.R., Schaefer T.L., Grace C.E., Skelton M.R., Johnson H.L., et al. Effects of neonatal (+)-methamphetamine on path integration and spatial learning in rats: effects of dose and rearing conditions. Int J Dev Neurosci 2008, 26:599-610.
70. Vorhees C.V., He E., Skelton M.R., Graham D.L., Schaefer T.L., Grace C.E., et al. Comparison of (+)-methamphetamine, +/-methylenedioxymethamphetamine, (+)-amphetamine and +/-fenfluramine in rats on egocentric learning in the Cincinnati water maze. Synapse 2011, 65:368-378.
71. Vorhees C.V., Graham D.L., Braun A.A., Schaefer T.L., Skelton M.R., Richtand N.M., et al. Prenatal immune challenge in rats: altered responses to dopaminergic and glutamatergic agents, prepulse inhibition of acoustic startle, and reduced route-based learning as a function of maternal body weight gain after prenatal exposure to poly IC. Synapse 2012, 66:725-737.
72. Wolff A.R., Bilkey D.K. Immune activation during mid-gestation disrupts sensorimotor gating in rat offspring. Behav Brain Res 2008, 190:156-159.
73. Wolff A.R., Bilkey D.K. The maternal immune activation (MIA) model of schizophrenia produces pre-pulse inhibition (PPI) deficits in both juvenile and adult rats but these effects are not associated with maternal weight loss. Behav Brain Res 2010, 213:323-327.
74. Wolff A.R., Cheyne K.R., Bilkey D.K. Behavioural deficits associated with maternal immune activation in the rat model of schizophrenia. Behav Brain Res 2011, 225:382-387.
75. Yee N., Ribic A., de Roo C.C., Fuchs E. Differential effects of maternal immune activation and juvenile stress on anxiety-like behaviour and physiology in adult rats: no evidence for the "double-hit hypothesis". Behav Brain Res 2011, 224:180-188.
76. Zhang Y., Cazakoff B.N., Thai C.A., Howland J.G. Prenatal exposure to a viral mimetic alters behavioural flexibility in male, but not female, rats. Neuropharmacology 2012, 62:1299-1307.
77. Zuckerman L., Weiner I. Post-pubertal emergence of disrupted latent inhibition following prenatal immune activation. Psychopharmacology (Berl) 2003, 169:308-313.
78. Zuckerman L., Weiner I. Maternal immune activation leads to behavioral and pharmacological changes in the adult offspring. J Psychiatr Res 2005, 39:311-323.
79. Zuckerman L., Rehavi M., Nachman R., Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology 2003, 28:1778-1789.
80. Zuckerman L., Rimmerman N., Weiner I. Latent inhibition in 35-day-old rats is not an "adult" latent inhibition: implications for neurodevelopmental models of schizophrenia. Psychopharmacology (Berl) 2003, 169:298-307.